Frailty score's role in predicting outcomes for cardiogenic shock
Part of Heart & circulation clinical trials.
This study looks at whether a simple frailty score (measuring how well someone can function) can help predict recovery for people hospitalized with cardiogenic shock, a condition where the heart suddenly can't pump enough blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had cardiogenic shock (a sudden drop in heart function) while in the hospital between January 2014 and September 2024.
- You were treated in an intensive care unit during that time.
- You agree to let the researchers use your medical data for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people with cardiogenic shock (a condition where the heart cannot pump enough blood for the body) to improve future care. You will not receive any new treatment, but your participation helps doctors understand and manage this condition better.
This study looks at what happens to people with cardiogenic shock while they are in the intensive care unit (ICU), including how their heart and blood circulation change over time. It may help doctors better understand the course of illness in this specific type of shock and improve care.
This trial looks at what happens to people after they survive a serious heart condition called cardiogenic shock, where the heart suddenly can't pump enough blood. Researchers want to understand recovery and improve care for survivors.
This trial checks whether a “frailty” rating (how physically/mentally vulnerable someone is) can predict the risk of death in ICU patients with sepsis shock. It may help doctors identify higher-risk patients earlier and tailor care.
This study looks at whether frailty (weakness and vulnerability) can help predict the risk of bleeding in older patients who have had a heart attack. The goal is to better identify who might need extra monitoring or different treatments to prevent dangerous bleeding.
This study looks at how frailty (overall weakness and vulnerability) affects treatment and recovery in older adults who come to the hospital with a heart attack. It may help doctors choose better treatments for patients like you.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.